Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179127 · ClinicalTrials.gov registry record · NA
Use of Insulin Glargine to Treat Diabetic Ketoacidosis
A NA study of Diabetic Ketoacidosis, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00179127: Completed NA study of Diabetic Ketoacidosis, sponsored by Vanderbilt University Medical Center.
NCT00179127 is a NA study of Diabetic Ketoacidosis that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 75 participants, above the 38-participant average among 3 other Diabetic Ketoacidosis trials with a reported enrollment target (97% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179127, a NA study of Diabetic Ketoacidosis, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects of the addition of insulin glargine during the early phase of moderate to severe Diabetic Ketoacidosis (DKA) in children. The investigators hypothesize that the addition of insulin glargine during the early phase of management of DKA will accelerate acidosis correction, decrease the length of insulin infusion, and decrease the total intensive care unit time in children admitted to the ICU.
Primary Outcome
Unable to find any data on this study. PI left Vanderbilt and there was not a publication.
Conditions Studied
Interventions
- DRUG saline
- DRUG glargine
Study Locations (1)
Tennessee
- Vanderbilt University Monroe Carell Children's Hospital - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2004-08 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT00179127 record still lists
NCT00179127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 38-participant average among 3 other Diabetic Ketoacidosis trials with a reported enrollment target (97% higher).
The record links to 1 condition, with Diabetic Ketoacidosis appearing as the primary indexed condition, and to 2 interventions - of which saline is the first listed.
NCT00179127 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00179127 about?
NCT00179127 is a clinical study titled "Use of Insulin Glargine to Treat Diabetic Ketoacidosis". The purpose of this study is to determine the effects of the addition of insulin glargine during the early phase of moderate to severe Diabetic Ketoacidosis (DKA) in children. The investigators hypothesize that the addition of insulin glargine during the early phase of management of DKA will accele...
What is the current status of trial NCT00179127?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2004-08. Estimated completion is 2012-09.
What conditions does trial NCT00179127 study?
This clinical trial studies the following conditions: Diabetic Ketoacidosis.
What interventions are being tested in trial NCT00179127?
The interventions under investigation include: saline (DRUG), glargine (DRUG).
Who is sponsoring clinical trial NCT00179127?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00179127 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Ketoacidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia